This inventor holds 6 USPTO granted patents and 1 published patent application and 6 EPO patents. Top assignees: Sanofi, Synthelabo. Active years: 2000-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gif sur Yvette, FR (2000)
- Paris, FR (2013 - 2018)
Company Filing History:
Years Active: 2000-2026
Title: Eykmar Fett – Innovator in Therapeutic Compounds
Introduction
Eykmar Fett is a distinguished inventor based in Paris, France, known for his significant contributions to the field of medicinal chemistry. With a portfolio of three patents, Fett has focused primarily on developing innovative compounds aimed at treating various AMPK-related diseases, including diabetes and obesity.
Latest Patents
Fett's most recent patents highlight his groundbreaking work in the pharmaceutical industry. The first patent, titled "Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases," presents a range of compounds that act as modulators of AMP-activated protein kinase (AMPK). These compounds show promise for therapeutic applications, specifically for managing conditions such as diabetes and obesity.
His second patent, "Thiadiazole and oxadiazole derivatives, preparation thereof and therapeutic use thereof," delves into the creation of novel compounds present either in base or acid addition salt forms. This invention not only outlines a method for preparing these compounds but also explores their therapeutic applications, further showcasing Fett's commitment to advancing medical science.
Career Highlights
Eykmar Fett has had a notable career, during which he has made significant contributions to the pharmaceutical sector. He has been associated with reputable companies such as Sanofi and Synthelabo, where he utilized his expertise to enhance the research and development of therapeutic compounds.
Collaborations
Collaboration has been a key element in Fett's career. He has worked alongside notable colleagues, including Christophe Philippo and Patrick Mougenot. These partnerships have undoubtedly enriched his research efforts and contributed to his innovative successes.
Conclusion
Eykmar Fett's inventive spirit and dedication to advancing medical treatments through innovative compounds are commendable. His contributions, particularly in the realm of AMPK-related disease treatments, reflect his status as an influential inventor in the pharmaceutical industry. With his continued work and research, Fett exemplifies the impact of innovation in improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile